Summary of Oncologic and Functional Outcomes

Roel Hompes; Marta Penna

doi:10.1055/s-0039-3402778

Clinics in Colon and Rectal Surgery, Inhaltsverzeichnis

Clin Colon Rectal Surg 2020; 33(03): 150-156
DOI: 10.1055/s-0039-3402778

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Summary of Oncologic and Functional Outcomes

Roel Hompes

¹Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

,

Marta Penna

²Department of Colorectal Surgery, Oxford University Hospitals, Oxford, United Kingdom

› Institutsangaben

Abstract

Large cohort and collaborative studies to date have shown that the short-term oncological outcomes appear to be at least as good as traditional laparoscopic surgery. These results need confirmation in randomized controlled trials, which are currently underway (GRECCAR 11 and COLOR III). The functional data on transanal total mesorectal excision is still very scarce and more mature data on quality of life and function outcomes are eagerly awaited.

Keywords

taTME - transanal total mesorectal excision - total mesorectal excision - rectal cancer - laparoscopy - oncologic outcomes - randomized controlled trials - functional outcome

Volltext

Referenzen

References
1 Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979; 22 (03) 277-281
2 Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2 (8514): 996-999
3 Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?. Br J Surg 1982; 69 (10) 613-616
4 Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133 (08) 894-899
5 Jayne D, Pigazzi A, Marshall H. , et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017; 318 (16) 1569-1580
6 Pecorelli N, Greco M, Amodeo S, Braga M. Small bowel obstruction and incisional hernia after laparoscopic and open colorectal surgery: a meta-analysis of comparative trials. Surg Endosc 2017; 31 (01) 85-99
7 Bartels SA, Vlug MS, Hollmann MW. , et al; Collaborative LAFA Study Group. Small bowel obstruction, incisional hernia and survival after laparoscopic and open colonic resection (LAFA study). Br J Surg 2014; 101 (09) 1153-1159
8 van der Pas MH, Haglind E, Cuesta MA. , et al; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013; 14 (03) 210-218
9 Jayne DG, Guillou PJ, Thorpe H. , et al; UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007; 25 (21) 3061-3068
10 Denost Q, Adam JP, Rullier A, Buscail E, Laurent C, Rullier E. Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg 2014; 260 (06) 993-999
11 Fleshman J, Branda M, Sargent DJ. , et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015; 314 (13) 1346-1355
12 Stevenson AR, Solomon MJ, Lumley JW. , et al. ALaCaRT Investigators. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCart randomized clinical trial. JAMA 2015; 314 (13) 1356-1363
13 Bondeven P, Hagemann-Madsen RH, Laurberg S, Pedersen BG. Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging. Br J Surg 2013; 100 (10) 1357-1367
14 Belizon A, Sardinha CT, Sher ME. Converted laparoscopic colectomy: what are the consequences?. Surg Endosc 2006; 20 (06) 947-951
15 Kang CY, Chaudhry OO, Halabi WJ. , et al. Outcomes of laparoscopic colorectal surgery: data from the Nationwide Inpatient Sample 2009. Am J Surg 2012; 204 (06) 952-957
16 Targarona EM, Balague C, Pernas JC. , et al. Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy. Ann Surg 2008; 247 (04) 642-649
17 Oh SJ, Shin JY. Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer. J Korean Surg Soc 2012; 82 (03) 165-171
18 Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 2010; 24 (05) 1205-1210
19 Lacy AM. , et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 2015; 221: 415-423
20 Penna M, Hompes R, Arnold S. , et al; TaTME Registry Collaborative. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 2017; 266 (01) 111-117
21 Penna M, Hompes R, Arnold S. , et al. International TaTME Registry Collaborative. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the international TaTME registry. Ann Surg 2019; 269 (04) 700-711
22 Tuech JJ, Karoui M, Lelong B. , et al. A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 2015; 261 (02) 228-233
23 Deijen CL, Tsai A, Koedam TW. , et al. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 2016; 20 (12) 811-824
24 Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery?. Colorectal Dis 2016; 18 (01) 19-36
25 Xu W, Xu Z, Cheng H. , et al. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis. Eur J Surg Oncol 2016; 42 (12) 1841-1850
26 Jiang HP, Li YS, Wang B. , et al. Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis. Surg Endosc 2018; 32 (06) 2632-2642
27 Perez D, Melling N, Biebl M. , et al. Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: a comparison of 115 cases. Eur J Surg Oncol 2018; 44 (02) 237-242
28 Lee KY, Shin JK, Park YA. , et al. Transanal endoscopic and transabdominal robotic total mesorectal excision for mid-to-low rectal cancer: comparison of short-term postoperative and oncologic outcomes by using a case-matched analysis. Ann Coloproctol 2018; 34 (01) 29-35
29 Emmertsen KJ, Laurberg S. ; Rectal Cancer Function Study Group. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg 2013; 100 (10) 1377-1387
30 Croese AD, Lonie JM, Trollope AF, Vangaveti VN, Ho YH. A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors. Int J Surg 2018; 56: 234-241
31 Chen TY, Wiltink LM, Nout RA. , et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer 2015; 14 (02) 106-114
32 Maurer CA. Urinary and sexual function after total mesorectal excision. Recent Results Cancer Res 2005; 165: 196-204
33 Pocard M, Zinzindohoue F, Haab F, Caplin S, Parc R, Tiret E. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery 2002; 131 (04) 368-372
34 Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002; 89 (12) 1551-1556
35 Araujo SE, Crawshaw B, Mendes CR, Delaney CP. Transanal total mesorectal excision: a systematic review of the experimental and clinical evidence. Tech Coloproctol 2015; 19 (02) 69-82
36 Penna M, Knol JJ, Tuynman JB, Tekkis PP, Mortensen NJ, Hompes R. Four anastomotic techniques following transanal total mesorectal excision (TaTME). Tech Coloproctol 2016; 20 (03) 185-191
37 Francis N, Penna M, Mackenzie H, Carter F, Hompes R. ; International TaTME Educational Collaborative Group. Consensus on structured training curriculum for transanal total mesorectal excision (TaTME). Surg Endosc 2017; 31 (07) 2711-2719
38 Atallah S, Gonzalez P, Chadi S, Hompes R, Knol J. Operative vectors, anatomic distortion, fluid dynamics and the inherent effects of pneumatic insufflation encountered during transanal total mesorectal excision. Tech Coloproctol 2017; 21 (10) 783-794
39 Rouanet P, Mourregot A, Azar CC. , et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum 2013; 56 (04) 408-415
40 Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36 (01) 77-97
41 Rouanet P, Saint-Aubert B, Lemanski C. , et al. Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation: long-term oncologic and functional results. Dis Colon Rectum 2002; 45 (03) 305-313 , discussion 313–315
42 Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, Rullier E. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surg Endosc 2016; 30 (11) 4924-4933
43 Koedam TW, van Ramshorst GH, Deijen CL. , et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017; 21 (01) 25-33
44 Veltcamp Helbach M, Koedam TWA, Knol JJ. , et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 2019; 33 (01) 79-87
45 McCulloch P, Altman DG, Campbell WB. , et al; Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009; 374 (9695): 1105-1112
46 Hompes R, Arnold S, Warusavitarne J. Towards the safe introduction of transanal total mesorectal excision: the role of a clinical registry. Colorectal Dis 2014; 16 (07) 498-501
47 Mandavia R, Knight A, Phillips J, Mossialos E, Littlejohns P, Schilder A. What are the essential features of a successful surgical registry? A systematic review. BMJ Open 2017; 7 (09) e017373
48 Lelong B, de Chaisemartin C, Meillat H. , et al; French Research Group of Rectal Cancer Surgery (GRECCAR). A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design. BMC Cancer 2017; 17 (01) 253
49 Deijen CL, Velthuis S, Tsai A. , et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016; 30 (08) 3210-3215